Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1053/j.ajkd.2015.01.034

http://scihub22266oqcxt.onion/10.1053/j.ajkd.2015.01.034
suck pdf from google scholar
C4696752!4696752 !25960299
unlimited free pdf from europmc25960299
    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\25960299 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117
pmid25960299
      Am+J+Kidney+Dis 2015 ; 66 (1 ): 133-46
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Calciphylaxis: risk factors, diagnosis, and treatment #MMPMID25960299
  • Nigwekar SU ; Kroshinsky D ; Nazarian RM ; Goverman J ; Malhotra R ; Jackson VA ; Kamdar MM ; Steele DJ ; Thadhani RI
  • Am J Kidney Dis 2015[Jul]; 66 (1 ): 133-46 PMID25960299 show ga
  • Calciphylaxis is a rare but devastating condition that has continued to challenge the medical community since its early descriptions in the scientific literature many decades ago. It is predominantly seen in patients with chronic kidney failure treated with dialysis (uremic calciphylaxis) but is also described in patients with earlier stages of chronic kidney disease and with normal kidney function. In this review, we discuss the available medical literature regarding risk factors, diagnosis, and treatment of both uremic and nonuremic calciphylaxis. High-quality evidence for the evaluation and management of calciphylaxis is lacking at this time due to its rare incidence and poorly understood pathogenesis and the relative paucity of collaborative research efforts. We hereby provide a summary of recommendations developed by a multidisciplinary team for patients with calciphylaxis.
  • |Animals [MESH]
  • |Arterioles/pathology [MESH]
  • |Biopsy [MESH]
  • |Calciphylaxis/diagnosis/epidemiology/*etiology/pathology/therapy [MESH]
  • |Case-Control Studies [MESH]
  • |Chronic Kidney Disease-Mineral and Bone Disorder/complications [MESH]
  • |Combined Modality Therapy [MESH]
  • |Comorbidity [MESH]
  • |Diabetic Nephropathies/complications [MESH]
  • |Disease Models, Animal [MESH]
  • |Electrolytes/blood [MESH]
  • |Fatal Outcome [MESH]
  • |Female [MESH]
  • |Humans [MESH]
  • |Hyperparathyroidism, Secondary/complications [MESH]
  • |Kidney Failure, Chronic/complications [MESH]
  • |Malnutrition/complications/diet therapy [MESH]
  • |Middle Aged [MESH]
  • |Obesity/complications [MESH]
  • |Pain Management [MESH]
  • |Rats [MESH]
  • |Risk Factors [MESH]
  • |Shock, Septic/etiology [MESH]
  • |Skin/blood supply/pathology [MESH]
  • |Thiosulfates/therapeutic use [MESH]
  • |Uremia/complications [MESH]
  • |Vitamin D Deficiency/complications [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box